192
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Comparative studies with EPR and MRI on the in vivo tissue redox status estimation using redox-sensitive nitroxyl probes: influence of the choice of the region of interest

, &
Pages 248-255 | Received 12 Sep 2017, Accepted 10 Jan 2018, Published online: 31 Jan 2018

References

  • Brasch RC, Nitecki DE, Brant-Zawadzki M, Enzmann DR, Wesbey GE, Tozer TN, et al. Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary report. Am J Roentgenol 1983;141:1019–1023.
  • Brasch RC, London DA, Wesbey GE, Tozer TN, Nitecki DE, Williams RD, et al. Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. Radiology 1983;147:773–779.
  • Brasch RC. Work in progress: methods of contrast enhancement for NMR imaging and potential applications. A subject review. Radiology 1983;147:781–788.
  • Griffeth LK, Rosen GM, Rauckman EJ, Drayer BP. Pharmacokinetics of nitroxide NMR contrast agents. Invest Radiol 1984;19:553–562.
  • Kroll C, Borchert HH. Metabolism of the stable nitroxyl radical 4-oxo-2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPONE). Eur J Pharm Sci 1999;8:5–9.
  • Bačić G, Pavićević A, Peyrot F. In vivo evaluation of different alterations of redox status by studying pharmacokinetics of nitroxides using magnetic resonance techniques. Redox Biol 2016;8:226–242.
  • Emoto MC, Yamato M, Sato-Akaba H, Yamada K, Fujii HG. Brain redox imaging in the pentylenetetrazole (PTZ)-induced kindling model of epilepsy by using in vivo electron paramagnetic resonance and a nitroxide imaging probe. Neurosci Lett 2015;608:40–44.
  • Emoto MC, Yamato M, Sato-Akaba H, Yamada K, Matsuoka Y, Fujii HG. Brain imaging in methamphetamine-treated mice using a nitroxide contrast agent for EPR imaging of the redox status and a gadolinium contrast agent for MRI observation of blood–brain barrier function. Free Radic Res 2015;49:1038–1047.
  • Redler G, Barth ED, Bauer KS Jr, Kao JP, Rosen GM, Halpern HJ. In vivo electron paramagnetic resonance imaging of differential tumor targeting using cis-3,4-di(acetoxymethoxycarbonyl)-2,2,5,5-tetramethyl-1-pyrrolidinyloxyl. Magn Reson Med 2014;71:1650–1656.
  • Bobko AA, Eubank TD, Voorhees JL, Efimova OV, Kirilyuk IA, Petryakov S, et al. In vivo monitoring of pH, redox status, and glutathione using L-band EPR for assessment of therapeutic effectiveness in solid tumors. Magn Reson Med 2012;67:1827–1836.
  • Kinoshita Y, Yamada K, Yamasaki T, Mito F, Yamato M, Kosem N, et al. In vivo evaluation of novel nitroxyl radicals with reduction stability. Free Radic Biol Med 2010;49:1703–1709.
  • Takeshita K, Kawaguchi K, Fujii-Aikawa K, Ueno M, Okazaki S, Ono M, et al. Heterogeneity of regional redox status and relation of the redox status to oxygenation in a tumor model, evaluated using electron paramagnetic resonance imaging. Cancer Res 2010;70:4133–4140.
  • Kamatari M, Yasui H, Ogata T, Sakurai H. Local pharmacokinetic analysis of a stable spin probe in mice by in vivo L-band ESR with surface-coil-type resonators. Free Radic Res 2002;36:1115–1125.
  • Takeshita K, Takajo T, Hirata H, Ono M, Utsumi H. In vivo oxygen radical generation in the skin of the protoporphyria model mouse with visible light exposure: an L-band ESR study. J Invest Dermatol 2004;122:1463–1470.
  • Sano H, Naruse M, Matsumoto K, Oi T, Utsumi H. A new nitroxyl-probe with high retention in the brain and its application for brain imaging. Free Radic Biol Med 2000;28:959–969.
  • Kuppusamy P, Li H, Ilangovan G, Cardounel AJ, Zweier JL, Yamada K, et al. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res 2002;62:307–312.
  • Ilangovan G, Li H, Zweier JL, Krishna MC, Mitchell JB, Kuppusamy P. In vivo measurement of regional oxygenation and imaging of redox status in RIF-1 murine tumor: effect of carbogen-breathing. Magn Reson Med 2002;48:723–730.
  • Matsumoto K, Bernardo M, Subramanian S, Choyke P, Mitchell JB, Krishna MC, Lizak MJ. MR assessment of changes of tumor in response to hyperbaric oxygen treatment. Magn Reson Med 2006;56:240–246.
  • Matsumoto K, Hyodo F, Matsumoto A, Koretsky AP, Sowers AL, Mitchell JB, Krishna MC. High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents. Clin Cancer Res 2006;12:2455–2462.
  • Matsumoto K. Utility decay rates of T1-weighted MRI contrast based on redox-sensitive paramagnetic nitroxyl contrast agents. Biol Pharm Bull 2009;32:711–716.
  • Hyodo F, Matsumoto K, Matsumoto A, Mitchell JB, Krishna MC. Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents. Cancer Res 2006;66:9921–9928.
  • Hyodo F, Murugesan R, Matsumoto K, Hyodo E, Subramanian S,. Mitchell JB, et al. Monitoring redox-sensitive paramagnetic contrast agent by EPRI, OMRI and MRI. J Magn Reson 2008;190:105–112.
  • Matsumoto A, Matsumoto S, Sowers AL, Koscielniak JW, Trigg NJ, Kuppusamy P, et al. Absolute oxygen tension (pO2) in murine fatty and muscle tissue as determined by EPR. Magn Reson Med 2005;54:1530–1535.
  • Doty FD, Entzminger G Jr, Hauck CD. Error-tolerant RF Litz coils for NMR/MRI. J Magn Reson 1999;140:17–31.
  • Koscielniak J, Devasahayam N, Moni MS, Kuppusamy P, Yamada K, Mitchell JB, et al. 300 MHz continuous wave electron paramagnetic resonance spectrometer for small animal in vivo imaging. Rev Sci Instrum 2000;71:4273–4281.
  • Matsumoto K, Yamasaki T, Nakamura M, Ishikawa J, Ueno M, Nakanishi I, et al. Brain contrasting ability of blood–brain-barrier-permeable nitroxyl contrast agents for magnetic resonance redox imaging. Magn Reson Med 2016;76:935–945.
  • Matsumoto K, Suzuki A, Washimi H, Hisamatsu A, Okajo A, Ui I, Endo K. Electron paramagnetic resonance decay constant and oxidative stresses in liver microsomes of the selenium-deficient rat. J Nutr Biochem 2006;17:677–681.
  • Matsumoto K, Narazaki M, Ikehira H, Anzai K, Ikota N. Comparisons of EPR imaging and T1-weighted MRI for efficient imaging of nitroxyl contrast agents. J Magn Reson 2007;187:155–162.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.